By Edward Winnick

NEW YORK (GenomeWeb News) - Fluidigm officials said Monday that the firm is focusing on growing its business and inking partnerships as it keeps its eye on a potential initial public offering.

The microfluidics and array manufacturer was forced to withdraw its proposed IPO amid the market meltdown a year ago. At the time, company officials said that Fluidigm would go public once the markets stabilized.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: researchers classify pancreatic cancer into four subtypes using sequencing, and more.

Genotyping analysis of measles in Ontario indicates the strain there didn't originate from Disneyland or Europe.

The UK Medical Research Council says the proposed path of a new train line could affect research at the Francis Crick Institute.

The House of Lords in the UK approves a bill to allow mitochondrial donation.